Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
26
CUTR Quote, Financials, Valuation and Earnings
Last price:
$0.36
Seasonality move
:
8.67%
Day range:
$0.34 - $0.37
52-week range:
$0.28 - $4.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.05x
P/B ratio:
--
Volume:
266.5K
Avg. volume:
405.7K
1-year change:
-85.85%
Market cap:
$7.3M
Revenue:
$212.4M
EPS (TTM):
-$6.58
Analysts' Opinion
-
Consensus RatingCutera has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Cutera has an estimated upside of 449.9% from its current price of $0.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.36.
Fair Value
-
According to the consensus of 0 analysts, Cutera has 449.9% upside to fair value with a price target of -- per share.
CUTR vs. S&P 500
-
Over the past 5 trading days, Cutera has overperformed the S&P 500 by 3.33% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cutera does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cutera revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Cutera reported revenues of $32.5M.
Earnings Growth
-
Cutera has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Cutera reported earnings per share of -$1.94.
Enterprise value:
370.1M
EV / Invested capital:
2.21x
Price / LTM sales:
0.05x
EV / EBIT:
--
EV / Revenue:
2.38x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-3.07x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$9.2M
Return On Assets:
-45.6%
Net Income Margin (TTM):
-92.59%
Return On Equity:
--
Return On Invested Capital:
-62.63%
Operating Margin:
-111.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $250.7M | $230.2M | $155.2M | $46.5M | $32.5M | |
| Gross Profit | $139.3M | $92.9M | $9.2M | $6.5M | $1.8M | |
| Operating Income | -$34.7M | -$104.2M | -$144.7M | -$40.9M | -$36.2M | |
| EBITDA | -$70.6M | -$94.8M | -$121.8M | -$39.2M | -$33.8M | |
| Diluted EPS | -$4.21 | -$5.72 | -$6.58 | -$2.22 | -$1.94 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $96.3M | $242.1M | $366.3M | $311.3M | $160.5M | |
| Total Assets | $123.4M | $268.4M | $428.2M | $406.6M | $234.4M | |
| Current Liabilities | $45.1M | $63.1M | $98.3M | $92.4M | $55.7M | |
| Total Liabilities | $71.4M | $213.1M | $412.7M | $522.7M | $487.3M | |
| Total Equity | $52M | $55.3M | $15.5M | -$116.1M | -$252.9M | |
| Total Debt | $7.2M | $134M | $300.3M | $418.1M | $420.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$47.3M | -$120.9M | -$116.6M | -$36.9M | -$24.7M | |
| Cash From Investing | -$220M | $165M | -$3.7M | $35.5M | -$173K | |
| Cash From Financing | $151.4M | $89.5M | -$924K | $229K | -$419K | |
| Free Cash Flow | -$62M | -$160.1M | -$120.4M | -$42.4M | -$24.9M | |
CUTR
Sector
Market Cap
$7.3M
$43.9M
Price % of 52-Week High
7.32%
45.73%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-85.85%
-29.11%
Beta (5-Year)
1.263
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.36
200-day SMA
Sell
Level
$1.26
Bollinger Bands (100)
Sell
Level
0.42 - 0.88
Chaikin Money Flow
Sell
Level
-47.6M
20-day SMA
Sell
Level
$0.38
Relative Strength Index (RSI14)
Sell
Level
42.44
ADX Line
Buy
Level
2.82
Williams %R
Neutral
Level
-74.4106
50-day SMA
Sell
Level
$0.48
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
10.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.3277)
Sell
CA Score
(Annual)
Level (-5.1132)
Sell
Beneish M-Score
(Annual)
Level (-1.4788)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (7.559)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.
Stock Forecast FAQ
In the current month, CUTR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CUTR average analyst price target in the past 3 months is --.
-
Where Will Cutera Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cutera share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Cutera?
Analysts are divided on their view about Cutera share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cutera is a Sell and believe this share price will drop from its current level to --.
-
What Is Cutera's Price Target?
The price target for Cutera over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CUTR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cutera is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CUTR?
You can purchase shares of Cutera via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cutera shares.
-
What Is The Cutera Share Price Today?
Cutera was last trading at $0.36 per share. This represents the most recent stock quote for Cutera. Yesterday, Cutera closed at $0.36 per share.
-
How To Buy Cutera Stock Online?
In order to purchase Cutera stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 0.09% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 7.53% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 6.1% over the past day.
